Case Report: Two Cases of Metastatic Pancreatoblastoma in Adults: Efficacy of Folfirinox and Implication of the Wnt/β-Catenin Pathway in Genomic Analysis.

Wnt/β-catenin adult chemotherapy—oncology genomics pancreatoblastoma

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2021
Historique:
received: 29 05 2020
accepted: 16 02 2021
entrez: 2 4 2021
pubmed: 3 4 2021
medline: 3 4 2021
Statut: epublish

Résumé

Pancreatoblastomas are unfrequent tumors usually found in children. We report two cases of metastatic pancreatoblastomas observed in young women. A systemic chemotherapy (FOLFIRINOX regimen) was associated with a disease control in one case and a partial response in the second with an improvement of general status for both. A high-throughput sequencing of the tumor described in both cases alteration in the Wnt/β-catenin pathway: a mutation in

Identifiants

pubmed: 33796447
doi: 10.3389/fonc.2021.564506
pmc: PMC8007973
doi:

Types de publication

Case Reports

Langues

eng

Pagination

564506

Informations de copyright

Copyright © 2021 Raoul, Oziel-Taieb, Lecomte, Adelaide, Guille, Chaffanet, Poizat, Heymann, Barbier and Bertucci.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absenceof any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Pancreatology. 2004;4(5):441-51; discussion 452-3
pubmed: 15256806
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Pancreatology. 2009;9(1-2):73-80
pubmed: 19077457
Nat Rev Endocrinol. 2018 Apr;14(4):229-249
pubmed: 29377879
Oncotarget. 2016 May 10;7(19):27208-19
pubmed: 27028851
J Clin Oncol. 2015 Mar 10;33(8):930-6
pubmed: 25624430
Gland Surg. 2015 Aug;4(4):322-8
pubmed: 26312218
Oncotarget. 2017 Nov 24;9(4):5492-5508
pubmed: 29435196
Genes (Basel). 2020 Aug 04;11(8):
pubmed: 32759724
Am J Pathol. 2001 Nov;159(5):1619-27
pubmed: 11696422
Eur J Cancer. 2011 Oct;47(15):2347-52
pubmed: 21696948
Mol Oncol. 2019 Aug;13(8):1684-1692
pubmed: 30972907
Cancer Res. 2018 Feb 15;78(4):865-876
pubmed: 29233928
Oncotarget. 2018 Jan 6;9(12):10818-10827
pubmed: 29535845
Br J Cancer. 2008 Dec 2;99(11):1891-9
pubmed: 19034281
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Trends Biochem Sci. 2018 Aug;43(8):623-634
pubmed: 30056837
Clin Cancer Res. 2012 Aug 15;18(16):4257-65
pubmed: 22896692
J Pathol. 2003 Feb;199(2):185-90
pubmed: 12533831
N Engl J Med. 2018 Mar 29;378(13):1177-1188
pubmed: 29590544
Clin Cancer Res. 2020 Jun 1;26(11):2477-2486
pubmed: 31992589
Pediatr Blood Cancer. 2012 May;58(5):827
pubmed: 21953767
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
Pancreatology. 2020 Apr;20(3):425-432
pubmed: 32156527
Neoplasia. 2012 Aug;14(8):742-56
pubmed: 22952427
Arch Pathol Lab Med. 2020 Jul 1;144(7):808-815
pubmed: 31869246
World J Gastroenterol. 2017 Dec 7;23(45):7945-7951
pubmed: 29259370

Auteurs

Jean-Luc Raoul (JL)

Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.

Sandrine Oziel-Taieb (S)

Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.

Thierry Lecomte (T)

Department of Hepatogastroenterology, CHU Tours, Tours, France.

José Adelaide (J)

Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Marseille, France.

Arnaud Guille (A)

Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Marseille, France.

Max Chaffanet (M)

Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Marseille, France.

Flora Poizat (F)

Department of Pathology, Institut Paoli-Calmettes, Marseille, France.

Marie-Françoise Heymann (MF)

Department of Pathology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.

Louise Barbier (L)

Department of Digestive Surgery, CHU Tours, Tours, France.

François Bertucci (F)

Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Predictive Oncology Laboratory, Centre de Recherche en Cancérologie de Marseille, Marseille, France.

Classifications MeSH